Sweden
· Delayed Price · Currency is SEK Bactiguard Holding AB Company Description
Bactiguard Holding AB (publ), a medical device company, provides infection prevention solutions in orthopedics, urology, intravascular/critical care, dental, and wound care therapeutic areas in the United States, Sweden, Malaysia, India, Bangladesh, Indonesia, the Kingdom of Saudi Arabia, and internationally.
The company's infection prevention solutions reduce the risk of infections and the use of antibiotics.
Its product portfolio consists of Bactiguard infection protection (BIP) Foley Catheter, an indwelling urinary catheter that reduces microbial adhesion; BIP Central Venous Catheter, which reduces the risk of catheter related bloodstream infection and antibiotics; BIP Endotracheal Tube, that reduces the ventilator associated pneumonia, antibiotics, and healthcare costs; BIP Endotracheal Tube Evac, a tube that combines the subglottic secretion drainage with coating to reduce microbial adhesion; and BIP Foley TempSensor, an indwelling urinary catheter that offers surveillance and infection prevention.
The company’s products also include Hydrocyn aqua, an antimicrobial solution and gel for improved wound healing; and surgical sutures comprising non-absorbable, natural absorbable, synthetic absorable, and specialty sutures.
In addition, it offers ZNN Bactiguard, an orthopedic trauma implants with infection prevention technology; and Aniocyn, a wound and skin care products for dogs, cats, horses, and other pets.
Bactiguard Holding AB (publ) was founded in 2005 and is headquartered in Stockholm, Sweden.
| Country | Sweden |
| Founded | 2005 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 217 |
| CEO | Christine Lind |
Contact Details
Address: Vasagatan 11 Stockholm, 111 20 | |
| Phone | 46 84 40 58 80 |
| Website | bactiguard.com |
Stock Details
| Ticker Symbol | BACTI.B |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0005878741 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Christine Lind | Chief Executive Officer |
| Patrick Fruergaard Bach | Chief Financial Officer |
| Mikael Sander | Chief Operating Officer |
| Nina Nornholm | Head of Corporate Communication and Investor Relations |
| Dr. Nathaniel Bachrach Ph.D. | Interim Head of Research & Development |